Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-16

Clinical Trial Update: Neurobiological Mechanisms of Pathological Rumination and Effects of Aripiprazole [NA]

View source ↗

Summary

This clinical trial update investigates the neurobiological mechanisms of pathological rumination in major depressive disorder and assesses the effects of aripi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abilify (aripiprazole)
  • Abilify (aripiprazole) (aripiprazole)

Snippet

Sponsor: Central South University | Conditions: Major Depressive Disorder (MDD), Rumination | NA | Status: ACTIVE_NOT_RECRUITING